Suppr超能文献

甲状腺髓样癌:诊断方法与病理分期的关系

Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.

作者信息

Wells S A, Baylin S B, Gann D S, Farrell R E, Dilley W G, Preissig S H, Linehan W M, Cooper C W

出版信息

Ann Surg. 1978 Sep;188(3):377-83. doi: 10.1097/00000658-197809000-00013.

Abstract

Medullary thyroid carcinoma (MTC) develops in virtually all patients affected with multiple endocrine neoplasia type II (MEN II), a disease inherited as an autosomal dominant trait. The thyroid tumor cells secrete calcitonin (CT) and the detection of elevated plasma levels (>300 pg/ml) of this hormone in MEN II kindred members strongly suggests the presence of MTC even though it may not be evident clinically. Intravenously administered calcium ion (Ca(++)) and pentagastrin (Pg) are potent CT secretagogues which are of particular value in establishing the early diagnosis of MTC. In evaluating seven kindreds with MEN II, we detected 90 patients with MTC. Depending on the method of diagnosis, they could be divided into three categories: Group 1; patients with no clinical evidence of MTC whose undetectable basal plasma calcitonin levels became elevated following intravenous Ca(++) or Pg, Group II; patients with no clinical evidence of MTC who had elevated basal plasma CT levels, and Group III; patients with clinically evident MTC. At the time of diagnosis of MTC, the patients in Group I were younger (20.5 +/- 1.9 years) than the patients in Group II (32.5 +/- 4.7 years, p < 0.005) and Group III (34.3 +/- 2.0, p < 0.00005). The incidence of residual MTC, as indicated by an elevated plasma CT level following provocative testing postoperatively, was less frequent in patients diagnosed biochemically ([6/34]; Group I, 4/26 and Group II, 2/8) than in those diagnosed clinically (Group III, 15/26, p < 0.002). Furthermore, regional nodes were involved less often in patients diagnosed biochemically ([5/28]; Group I, 2/22 and Group II, 3/6) than in those diagnosed clinically (Group III, 15/24, p < 0.02). Distant metastases were only evident in Group III patients. Patients with MEN II who had the diagnosis of MTC established biochemically rather than clinically, had a more favorable pathological stage of disease at the time of thyroidectomy. This was especially true if the biochemical diagnosis had been by provocative testing.

摘要

几乎所有患有II型多发性内分泌腺瘤病(MEN II)的患者都会发生甲状腺髓样癌(MTC),MEN II是一种常染色体显性遗传疾病。甲状腺肿瘤细胞分泌降钙素(CT),在MEN II家族成员中检测到血浆中该激素水平升高(>300 pg/ml)强烈提示MTC的存在,即便临床上可能并不明显。静脉注射钙离子(Ca(++))和五肽胃泌素(Pg)是有效的CT促分泌剂,在MTC的早期诊断中具有特殊价值。在评估7个MEN II家系时,我们检测到90例MTC患者。根据诊断方法,他们可分为三类:第1组,无MTC临床证据,基础血浆降钙素水平不可测,但静脉注射Ca(++)或Pg后升高的患者;第II组,无MTC临床证据,但基础血浆CT水平升高的患者;第III组,有MTC临床证据的患者。在诊断MTC时,第1组患者(20.5±1.9岁)比第II组患者(32.5±4.7岁,p<0.005)和第III组患者(34.3±2.0岁,p<0.00005)年轻。术后激发试验后血浆CT水平升高表明存在残留MTC,生化诊断的患者([6/34];第1组,4/26;第II组,2/8)比临床诊断的患者(第III组,15/26,p<0.002)发生率低。此外,生化诊断的患者([5/28];第1组,2/22;第II组,3/6)区域淋巴结受累比临床诊断的患者(第III组,15/24,p<0.02)少。远处转移仅在第III组患者中明显。通过生化而非临床诊断MTC的MEN II患者,在甲状腺切除时疾病的病理分期更有利。如果生化诊断是通过激发试验,则尤其如此。

相似文献

10
Chromogranin A as tumor marker in medullary thyroid carcinoma.
Thyroid. 1992 Spring;2(1):5-10. doi: 10.1089/thy.1992.2.5.

引用本文的文献

本文引用的文献

1
A short calcium infusion in the diagnosis of medullary thyroid carcinoma.
J Clin Endocrinol Metab. 1974 Jul;39(1):108-11. doi: 10.1210/jcem-39-1-108.
4
A radioimmunoassay for human calcitonin M.人降钙素M的放射免疫测定法
Lancet. 1969 Jul 12;2(7611):74-7. doi: 10.1016/s0140-6736(69)92389-7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验